A chimeric antigen receptor tailored to integrate complementary activation signals potentiates the antitumor activity of NK cells
Hence, NK receptor-based domains hold great promise for the future of NK-CAR design with potentially significant therapeutic benefits.
Authors
- S. Yun (ORCID: https://orcid.org/0009-0004-8999-778X)
- Eunbi Yi (ORCID: https://orcid.org/0000-0001-8994-6107)
- Hun Sik Kim (ORCID: https://orcid.org/0000-0002-5729-6581)
- Eunbi Lee (ORCID: https://orcid.org/0009-0004-8977-7859)
- Hyeon Ho Lee (ORCID: https://orcid.org/0000-0002-0375-8410)
- Hyo Jin Park (ORCID: https://orcid.org/0000-0002-2198-5211)
Institutions
- Ulsan College (KR)
- Asan Medical Center (KR)
- University of Ulsan (KR)
- Stem Cell Institute (PA)
Publication Details
- Journal
- Journal of Experimental & Clinical Cancer Research
- Published
- 2025-03-06
- DOI
- https://doi.org/10.1186/s13046-025-03351-5
- Citations
- 13
- Primary Topic
- Immune Cell Function and Interaction
- Type
- article
- Field-Weighted Citation Impact
- 10.37
Funders
- National Research Foundation of Korea
- Asan Institute for Life Sciences, Asan Medical Center